ICD-10-CM Billable Code

M05.662

Rheumatoid arthritis of left knee with involvement of other organs and systems

Clinical Classification Guidelines

Medical Intelligence & Overview

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily affects the joints. When it involves the left knee, it can cause significant pain, swelling, and stiffness. In some cases, RA extends beyond the joints to involve other organs and systems in the body, leading to more complex health concerns. The ICD-10 code M05.662 specifically describes cases of rheumatoid arthritis impacting the left knee along with systemic involvement, indicating a widespread form of the disease that affects multiple body parts and functions.

Causes & Symptoms

Clinical Causes: Genetic predisposition: Certain genes may increase susceptibility to RA. Immune system malfunction: The immune system mistakenly attacks the body's joint tissues. Environmental factors: Exposure to certain pathogens or environmental triggers may play a role. Hormonal influences: Hormonal changes, particularly in women, can be associated with RA development. Smoking: Tobacco use has been linked to a higher risk of developing RA.

Key Symptoms: Persistent joint pain in the left knee, often accompanied by swelling and warmth. Stiffness, especially noticeable in the morning or after periods of inactivity. Reduced range of motion due to joint pain and swelling. Tenderness upon touch or movement of the affected joint. General systemic symptoms such as fatigue, fever, and malaise, especially in advanced stages. Signs of systemic involvement may include inflammation of organs such as the lungs, heart, eyes, or skin. Unusual fatigue and weight loss may also be observed.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive assessment including clinical evaluation, medical history, and laboratory tests. Key diagnostic steps include: - Physical examination of joints to detect swelling, warmth, and tenderness. - Blood tests such as rheumatoid factor (RF), anti-CCP antibodies, and markers of inflammation (ESR, CRP). - Imaging studies like X-rays or ultrasounds to identify joint damage or erosion. - Evaluation for systemic involvement through additional tests if symptoms point to other organ involvement. A multidisciplinary approach helps confirm the diagnosis and assess the extent of systemic disease.

Treatment Protocols: While specific treatments are determined by healthcare providers, management generally aims to control inflammation, relieve symptoms, and prevent joint and organ damage. Common approaches include: - Disease-modifying antirheumatic drugs (DMARDs) like methotrexate to slow disease progression. - Biological agents that target specific components of the immune system. - Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids to manage pain and inflammation. - Physical therapy and occupational therapy to improve joint function and mobility. - Regular monitoring and adaptation of treatment plans to address systemic involvement. - Lifestyle modifications such as exercise, diet, and smoking cessation to support overall health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.662 a billable ICD-10 code?
Yes, M05.662 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.662?
Clinical documentation must specify the nature of Rheumatoid arthritis of left knee with involvement of other organs and systems and any associated comorbidities for accurate reporting.

Cite this Clinical Reference